Got an email from my building in NYC they are going back to mask mandate in the building at all times....
Bam! Confluent, Inc. (CFLT)- NasdaqGS - NasdaqGS Real Time Price. Currency in USD 41.54+2.35 (+6.00%)<------ At close: 4:00PM EDT
Strong from Noon on.... Cutera, Inc. (CUTR)- Insider by stk********* NasdaqGS - NasdaqGS Real Time Price. Currency in USD 53.61+1.66 (+3.20%)<-- Van!
Van-- Josh I'm so angry that bastard that rich MFer he is in Klarna private placement some shit he said so on TV..! I want to be rich like that!!! Why are we not in these companies earlier!!! Private.... Klarna is my favorite!! I'll invest now!!!!
WHAT DID I TELL YOU ABOUT BUY NOW PAY LATER!!!!-- SHOULD WE GET BACK IN SNAP-? Snap Inc. (SNAP)- I THINK IT'S BUY TIME AGAIN! NYSE - Nasdaq Real Time Price. Currency in USD 73.50-0.92 (-1.24%) At close: 4:00PM EDT
VAN IS THERE A BUY OUT OR NOT!! Acreage Holdings, Inc. (ACRHF)- DID CANOPY BUY THEM? 3.4200+0.0100 (+0.29%) At close: 3:58PM Acreage Announces Second Quarter 2021 Earnings Date Acreage Holdings, Inc. July 22, 2021 NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) --Acreage Holdings, Inc.(“Acreage”) (CSE:ACRG.A.U, ACRG.B.U), (OTCQX: ACRHF, ACRDF) a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today announced it will report its second quarter 2021 financial results for the period ending June 30, 2021 on August 9, 2021 ....
VAN I'M NO EXPERT BUT THIS IS ACTING LIKE IT MAY EXPLODE. Verb Technology Company, Inc. (VERB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD 2.4500+0.1200 (+5.15%)<------- At close: 4:00PM EDT
$TBIO Stoney! Exclusive-Sanofi Offers to Buy U.S. MRNA Partner Translate Bio -Sources By Reuters | Aug. 2, 2021, at 5:40 p.m. PARIS (Reuters) - Sanofi has offered to buy U.S. biotech company Translate Bio, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race. An offer for all Translate Bio shares had been made to the U.S. group's shareholders, the sources said. The persons declined to be identified due to the confidentiality of the talks. Translate's board was expected to meet later on Monday to discuss the offer, one of the sources said. The second source said Sanofi's directors had met on Sunday to discuss the potential deal. A spokeswoman for Sanofi declined to comment and Translate Bio did not respond to requests by email and phone for comment.